Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 1
2008 2
2009 2
2010 8
2011 2
2012 3
2013 5
2014 1
2015 2
2016 3
2017 6
2018 12
2019 17
2020 16
2021 13
2022 28
2023 19
2024 14

Text availability

Article attribute

Article type

Publication date

Search Results

131 results

Results by year

Filters applied: . Clear all
Page 1
Perioperative management and clinical outcomes of peristomal pyoderma gangrenosum.
Becker SL, Rios-Duarte JA, Morrison GM, Xia E, Mostaghimi A, Himed S, Kaffenberger BH, Zhang D, Shields BE, Cogen AL, Ortega-Loayza AG. Becker SL, et al. Among authors: ortega loayza ag. Arch Dermatol Res. 2024 Mar 6;316(4):98. doi: 10.1007/s00403-024-02826-3. Arch Dermatol Res. 2024. PMID: 38446235 Review.
An approach to diagnosis and management of patients with pyoderma gangrenosum from an international perspective: results from an expert forum.
Haddadin OM, Ortega-Loayza AG, Marzano AV, Davis MDP, Dini V, Dissemond J, Hampton PJ, Navarini AA, Shavit E, Tada Y, Yamamoto T, Alavi AA. Haddadin OM, et al. Among authors: ortega loayza ag. Arch Dermatol Res. 2024 Feb 24;316(3):89. doi: 10.1007/s00403-024-02829-0. Arch Dermatol Res. 2024. PMID: 38400852 No abstract available.
Eligibility Criteria for Active Ulcerative Pyoderma Gangrenosum in Clinical Trials: A Delphi Consensus on Behalf of the UPGRADE (Understanding Pyoderma Gangrenosum: Review and Assessment of Disease Effects) Group.
Kamal K, Xia E, Li SJ, Alavi A, Cogen AL, Firooz A, Marzano AV, Kaffenberger BH, Sibbald C, Fernandez AP, Callen JP, Dissemond J, Gontijo JRV, Shams K, Gerbens LA, French LE, Gould LJ, Bissonnette R, Shaigany S, Tolkachjov S, Yamamoto T, Wei-Ting Huang W, Ortega-Loayza AG, Mostaghimi A. Kamal K, et al. Among authors: ortega loayza ag. J Invest Dermatol. 2023 Dec 16:S0022-202X(23)03193-7. doi: 10.1016/j.jid.2023.12.006. Online ahead of print. J Invest Dermatol. 2023. PMID: 38110114
Subjective assessments in pyoderma gangrenosum diagnostic frameworks undermine framework agreement.
Nusbaum KB, Boettler M, Korman AM, Alavi A, Alloo A, Dissemond J, French LE, Huang WW, Kolios AGA, Marzano AV, Micheletti RG, Mostaghimi A, Ortega-Loayza AG, Rosenbach M, Schreml S, Tolkachjov SN, Kaffenberger BH. Nusbaum KB, et al. Among authors: ortega loayza ag. Int J Dermatol. 2024 Feb;63(2):e67-e69. doi: 10.1111/ijd.16952. Epub 2023 Dec 3. Int J Dermatol. 2024. PMID: 38044552 No abstract available.
131 results